• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8/8/25 9:00:38 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care
    Get the next $AVAH alert in real time by email
    8-K
    false000183233200018323322025-08-082025-08-08

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): August 08, 2025

     

     

    img25598498_0.jpg

    Aveanna Healthcare Holdings Inc.

    (Exact name of Registrant as Specified in Its Charter)

     

     

    Delaware

    001-40362

    81-4717209

    (State or Other Jurisdiction
    of Incorporation)

    (Commission File Number)

    (IRS Employer
    Identification No.)

     

     

     

     

     

    400 Interstate North Parkway SE

     

    Atlanta, Georgia

     

    30339

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: 770 441-1580

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:


    Title of each class

     

    Trading
    Symbol(s)

     


    Name of each exchange on which registered

    Common Stock, par value $0.01 per share

     

    AVAH

     

    The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     


    Item 7.01 Regulation FD Disclosure.

    On August 8, 2025, Aveanna Healthcare Holdings Inc. (the "Company", "we", "us", or "our") made available a financial presentation to investors. A copy of the presentation is attached hereto as Exhibit 99.1 and incorporated by reference in this Item 7.01. A copy of the presentation is also available on our website at ir.aveanna.com.

     

    Use of our Website and Social Media to Distribute Material Company Information

     

    We use our website as a channel of distribution for important Company information. We routinely post on our website important information, including press releases, investor presentations and financial information, which may be accessed by clicking on the “Investors” section of www.aveanna.com. We also use our website to expedite public access to time-critical information regarding our Company in advance of or in lieu of distributing a press release or a filing with the SEC disclosing the same information. Therefore, investors should look to the “Investors” section of our website for important and time-critical information. Visitors to our website can also register to receive automatic e-mail and other notifications alerting them when certain new information is made available on our website. Information contained on, or accessible through, our website is not a part of and is not incorporated by reference in this Current Report on Form 8-K.

     

    The information contained in this Item 7.01, including in Exhibit 99.1 attached hereto, is “furnished” and not “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act, except to the extent such other filing specifically incorporates such information by reference.

    Item 9.01 Financial Statements and Exhibits.

    (d) Exhibits.

     

    Exhibit Number

     

     

    Description

    99.1

     

    Aveanna Investor Presentation - August 2025

    104

     

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     

     

     

    AVEANNA HEALTHCARE HOLDINGS INC.

     

     

     

     

    Date:

    August 8, 2025

    By:

    /s/ Matthew Buckhalter

     

     

     

    Matthew Buckhalter
    Chief Financial Officer
    (Principal Financial Officer)

     


    Get the next $AVAH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVAH

    DatePrice TargetRatingAnalyst
    8/19/2025$9.50Equal Weight → Overweight
    Barclays
    8/19/2025$8.00Sell → Neutral
    UBS
    7/21/2025$6.00Hold → Buy
    Jefferies
    7/2/2025$5.50Equal Weight
    Barclays
    12/13/2023Neutral → Underweight
    JP Morgan
    11/30/2023$1.50Sell
    UBS
    5/12/2023Strong Buy → Mkt Perform
    Raymond James
    1/27/2023$2.00 → $1.00Neutral → Underperform
    Credit Suisse
    More analyst ratings

    $AVAH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aveanna to Participate at the Deutsche Bank Healthcare Summit

    ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Deutsche Bank Healthcare Summit in New York on September 10, 2025. Management will host 1x1 investor meetings that day. About Aveanna Healthcare Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 38 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of e

    8/19/25 7:30:05 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2025 Outlook

    Second Quarter Revenue was $589.6 million, a 16.8% increase over the prior year periodSecond Quarter Net income was $27.0 million, a 94.3% increase over the prior year periodAdjusted EBITDA for Q2 2025 was $88.4 million, a 93.6% increase over the prior year periodIncreased Full Year 2025 Revenue guidance greater than $2.3 billion, updated from greater than $2.15 billion Increased Full Year 2025 Adjusted EBITDA guidance greater than $270 million, updated from greater than $207 million ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populat

    8/7/25 6:30:05 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Announces Second Quarter 2025 Earnings Release Date and Conference Call

    ATLANTA, July 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August 7, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13754011. The replay will be available until August 14, 20

    7/17/25 6:30:51 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Aveanna Healthcare Holdings Inc.

    SCHEDULE 13G/A - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

    8/11/25 3:19:31 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form 10-Q/A filed by Aveanna Healthcare Holdings Inc.

    10-Q/A - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

    8/8/25 8:00:32 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

    8/8/25 9:00:38 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Administrative Officer Reisz Edwin C. was granted 139,665 shares and covered exercise/tax liability with 49,783 shares, increasing direct ownership by 7% to 1,371,497 units (SEC Form 4)

    4/A - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

    7/16/25 7:00:04 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Large owner J.H. Whitney Equity Partners Vii, Llc disposed of 81,882 shares (SEC Form 4)

    4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

    7/11/25 9:17:51 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Large owner Vigano Paul R disposed of 81,882 shares (SEC Form 4)

    4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

    7/11/25 9:14:06 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aveanna upgraded by Barclays with a new price target

    Barclays upgraded Aveanna from Equal Weight to Overweight and set a new price target of $9.50

    8/19/25 8:29:17 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna upgraded by UBS with a new price target

    UBS upgraded Aveanna from Sell to Neutral and set a new price target of $8.00

    8/19/25 8:29:17 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna upgraded by Jefferies with a new price target

    Jefferies upgraded Aveanna from Hold to Buy and set a new price target of $6.00

    7/21/25 8:21:50 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Leadership Updates

    Live Leadership Updates

    View All

    Aveanna Healthcare Holdings Announces Appointment of New Director

    ATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November 1, 2024. "I am delighted to announce the appointment of Brent Layton to our Aveanna Board of Directors. Brent brings a wealth of healthcare knowledge from over 20 years of leadership at Centene Corporation. Brent's experience working with state and feder

    11/4/24 7:30:02 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces Appointment of Chief Legal Officer and Secretary

    ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. "I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of healthcare industry and regulatory experience. I have known Jerry for more than a decade and have great trust in his leadership and counsel. It is a pleasure to welcome Jerry to our Aveanna family, and

    4/3/24 6:30:06 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces Appointment of Chief Financial Officer

    ATLANTA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Matt Buckhalter to serve as Chief Financial Officer and continuing in the role of Principal Financial Officer, effective January 1, 2024. Mr. Buckhalter was appointed to serve as Interim Chief Financial Officer and Principal Financial Officer in July, 2023. "I am pleased to announce the promotion of Matt to the Chief Financial Officer position. Matt has provided strong financial leadership and continuity as we build on our recent successes to t

    12/11/23 7:30:00 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Financials

    Live finance-specific insights

    View All

    Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2025 Outlook

    Second Quarter Revenue was $589.6 million, a 16.8% increase over the prior year periodSecond Quarter Net income was $27.0 million, a 94.3% increase over the prior year periodAdjusted EBITDA for Q2 2025 was $88.4 million, a 93.6% increase over the prior year periodIncreased Full Year 2025 Revenue guidance greater than $2.3 billion, updated from greater than $2.15 billion Increased Full Year 2025 Adjusted EBITDA guidance greater than $270 million, updated from greater than $207 million ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populat

    8/7/25 6:30:05 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Announces Second Quarter 2025 Earnings Release Date and Conference Call

    ATLANTA, July 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August 7, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13754011. The replay will be available until August 14, 20

    7/17/25 6:30:51 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook

    First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period Adjusted Net income was $21.4 million, an increase of $27.1 million compared to Q1 2024 Adjusted EBITDA for Q1 2025 was $67.4 million, a 93.1% increase as compared to Q1 2024Revised Full Year 2025 Revenue guidance greater than $2.15 billion, updated from a range of $2.10 - $2.12 billion Revised Full Year 2025 Adjusted EBITDA guidance greater than $207 million, updated from a range of $190 - $194 million ATLANTA, May 08, 20

    5/8/25 6:30:59 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

    SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

    2/14/24 4:00:42 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

    SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

    2/14/22 6:43:51 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care